Home Daily Stock Opinions and Ratings Boston Scientific Corp (BSX-N)

Trending stocks today

Brookfield Infrastructure Partners Sun Life Financial Inc Crescent Point Energy Corp Rogers Communications (B) Pfizer Inc Minto Apartment REIT Winpak Ltd. Arc Resources Ltd Cenovus Energy Headwater Exploration Inc. Whitecap Resources Mainstreet Equity Corp Parex Resources Inc. Visa Inc. Canadian Pacific Rail Canadian Natural Rsrcs Zscaler Inc. VMware Inc. PVH Corp

Boston Scientific Corp (BSX-N)

90 watching

NYSE:BSX

51.50
0.02 (0.04%) 1d
Jun 1, 2023, 8:00 pm
0
DON'T BUY

Boston Scientific Corp(BSX-N)

17/04/2023
Boston Scientific Corp

It is at a new high in terms of price but not new highs in terms of Price/Book. There is no yield and a 25% downside risk.

biotechnology / pharmaceutical
Ross Healy
$51.610
Unknown
UnlockRating
BUY

Boston Scientific Corp(BSX-N)

10/04/2023
Boston Scientific Corp

It is a leader in the field so the price is at a premium for a good reason. Has had a good bounce. You could also look at MedTech and Thermo-Fisher.

biotechnology / pharmaceutical
Robert Lauzon
$50.340
Owned
UnlockRating
TOP PICK

Boston Scientific Corp(BSX-N)

28/12/2022
Boston Scientific Corp
World's leader in med tech. He's doubling down on US healthcare. Leader in cardio surgical technology. Healthcare, neglected through Covid, will be a very high growth area for the next couple of years. No dividend. (Analysts’ price target is $49.96)
biotechnology / pharmaceutical
Brendan Caldwell
$45.780
Owned
UnlockRating
PARTIAL SELL

Boston Scientific Corp(BSX-N)

06/12/2022
Boston Scientific Corp
Can be a safe haven stock. Health care offers defence. But BSX has had a big run and he expects this market to roll over a bit. Take some profits and wait for opportunities, which could mean buying this back in 2-3 months. Has fantastic fundamentals, but valuation is rich.
biotechnology / pharmaceutical
Andrew Pyle
N/A
No
UnlockRating
BUY

Boston Scientific Corp(BSX-N)

03/02/2022
Boston Scientific Corp
Likes it very much. Higher growth. Under pressure post-earnings. Predominantly everything cardiovascular. Covid put off elective surgeries, and these are starting to return. For the rest of 2022, increased volume might offset inflationary pressures.
biotechnology / pharmaceutical
Paul MacDonald
$42.755
Unknown
UnlockRating
WAIT

Boston Scientific Corp(BSX-N)

06/12/2021
Boston Scientific Corp
She has owned it for many years and it has not done anything. The COVID scares cast shadows over medical procedure demand. As a medical device provider it has faced head winds. Demand should ramp back up, but it will take confidence by patients to return for procedures.
biotechnology / pharmaceutical
Jennifer Radman
$41.155
Owned
UnlockRating
PAST TOP PICK

Boston Scientific Corp(BSX-N)

23/11/2021
Boston Scientific Corp
(A Top Pick Dec 01/20, Up 22%) Covid delayed surgeries. Labour shortages. Both are holding the stock back, but will improve. Solid, long-term core investment.
biotechnology / pharmaceutical
Bruce Murray
$40.030
Owned
UnlockRating
HOLD

Boston Scientific Corp(BSX-N)

12/11/2021
Boston Scientific Corp
Holds other healthcare plays. There is a good place for these names in portfolios. The organic growth from resuming treatment and surgeries will be interesting to follow. Wouldn't worry about the pullback.
biotechnology / pharmaceutical
James Telfser
$42.070
Unknown
UnlockRating
WAIT

Boston Scientific Corp(BSX-N)

11/11/2021
Boston Scientific Corp
BSX vs. MDT Two great companies. In the implantable medical device business. Loves the area. Too expensive, as investors have flocked to them and the multiple has increased. Would love to own both if prices came down substantially.
biotechnology / pharmaceutical
Lorne Steinberg
$41.895
No
UnlockRating
BUY

Boston Scientific Corp(BSX-N)

25/10/2021
Boston Scientific Corp
Medical device maker. It has been a bit of a laggard. It was the market darling until 2019 and then they started to have a couple of misses and issues with products. He thinks these are all transient issues. He thinks in 2022 they will grow revenue in high single digits. He is going to stick with it and would buy it here.
biotechnology / pharmaceutical
Jamie Murray
$44.490
Owned
UnlockRating
PAST TOP PICK

Boston Scientific Corp(BSX-N)

30/08/2021
Boston Scientific Corp
(A Top Pick Dec 01/20, Up 33%) He would buy it again. They had a decade of no-growth. In the last 3-5 years they introduced successful products that got their revenue going again. A lot of their procedures are not necessary today but will be over the next few months. The volumes are coming back. It is at the cheaper end of a lot of healthcare stocks.
biotechnology / pharmaceutical
Bruce Murray
$44.830
Owned
UnlockRating
BUY ON WEAKNESS

Boston Scientific Corp(BSX-N)

17/08/2021
Boston Scientific Corp
It's one of Abbott's biggest competitors. It's in an attractive industry, medical equipment, where companies earn good returns. But BSX's valuation is high, gotten ahead of itself (like the whole sector), so wait for a pullback. BSX had a strong quarter as non-elective surgeries have bounced back, but its PE is rich.
biotechnology / pharmaceutical
Chris Blumas
$45.170
Unknown
UnlockRating
PAST TOP PICK

Boston Scientific Corp(BSX-N)

12/07/2021
Boston Scientific Corp
(A Top Pick Jul 14/20, Up 23%) It had a couple of disappointing news items involving a couple of their products. They are playing catch-up on elective surgeries. It is one he really likes and continues to hold.
biotechnology / pharmaceutical
Jamie Murray
$43.510
Owned
UnlockRating
TOP PICK

Boston Scientific Corp(BSX-N)

14/06/2021
Boston Scientific Corp
It is a medical device company and people are starting to be able to get in to see their doctor and take care of things. A lot of their revenues are tied to non-deferrable procedures. That is positive for the whole group and they have company-specific catalysts also. (Analysts’ price target is $49.00)
biotechnology / pharmaceutical
Jennifer Radman
$42.395
Owned
UnlockRating
HOLD

Boston Scientific Corp(BSX-N)

23/04/2021
Boston Scientific Corp
Looking at the longer term chart, they had a dip around the time China announced first cases of covid. Underperformed relative to others, like other mid-tech companies. Lots of procedures were delayed in hospitals. Now there will be catch up for this. At these levels, there is still some room to run. Could go to $48 range.
biotechnology / pharmaceutical
Darren Sissons
$42.610
Owned
UnlockRating
Showing 1 to 15 of 54 entries
Next PageNext Page

Boston Scientific Corp(BSX-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 2

Total Signals / Votes : 3

Stockchase rating for Boston Scientific Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Boston Scientific Corp(BSX-N) Frequently Asked Questions

What is Boston Scientific Corp stock symbol?

Boston Scientific Corp is a American stock, trading under the symbol BSX-N on the New York Stock Exchange (BSX). It is usually referred to as NYSE:BSX or BSX-N

Is Boston Scientific Corp a buy or a sell?

In the last year, 3 stock analysts published opinions about BSX-N. 1 analyst recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Boston Scientific Corp.

Is Boston Scientific Corp a good investment or a top pick?

Boston Scientific Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Boston Scientific Corp.

Why is Boston Scientific Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Boston Scientific Corp worth watching?

3 stock analysts on Stockchase covered Boston Scientific Corp In the last year. It is a trending stock that is worth watching.

What is Boston Scientific Corp stock price?

On 2023-06-01, Boston Scientific Corp (BSX-N) stock closed at a price of $51.5.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

ATD-TAlimentation Couche-Tard
Alimentation Couche-Tard
$66.63
0.90 (1.33%)
CCL-NCarnival Corp.
Carnival Corp.
$11.85
0.62 (4.97%)
ENB-TEnbridge
Enbridge
$48.71
0.92 (1.85%)
BAM-TBrookfield Asset Management (A)
Brookfield Asset Management (A)
$41.39
-0.11 (-0.27%)
BN-TBrookfield Corp
Brookfield Corp
$41.05
0.28 (0.68%)
Advertising

Today's Top Picks

PVH-NPVH Corp
PVH Corp
$77.82
-8.20 (-11.78%)
VMW-NVMware Inc.
VMware Inc.
$134.50
-1.79 (-1.35%)
ZS-QZscaler Inc.
Zscaler Inc.
$135.13
-0.35 (-0.26%)
CNQ-TCanadian Natural Rsrcs
Canadian Natural Rsrcs
$73.82
0.69 (0.93%)
CP-TCanadian Pacific Rail
Canadian Pacific Rail
$102.63
-0.81 (-0.80%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

JNJ-NJohnson & Johnson
Johnson & Johnson
$154.54
-0.52 (-0.34%)
NTR-TNutrien Ltd.
Nutrien Ltd.
$71.89
0.37 (0.51%)
AP.UN-TAllied Properties REIT
Allied Properties REIT
$22.30
0.08 (0.36%)
M-NMacys Inc. (formerly Federated Department Stores)
Macys Inc. (formerly Federated Department Stores)
$13.66
0.06 (0.47%)
DVN-NDevon Energy Corp
Devon Energy Corp
$46.78
0.68 (1.43%)

Most Recent Experts

Curry

Zachary Curry

Davis-Rea Ltd.

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Nuttall

Eric Nuttall

Ninepoint Partners

Stockchase

Stockchase Insights

5i Research

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.